Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Saved in:

Bibliographic Details
Published in:	Journal for Immunotherapy of Cancer vol. 13, no. 2 (Feb 2025), p. e009352
Main Author:	Eigentler, Thomas
Other Authors:	Thomas, Ioannis, Samoylenko, Igor, Erdmann, Michael, Heinzerling, Lucie, Ochsenreither, Sebastian, Krauss, Jürgen, Oberoi, Arjun, Robert, Caroline, Lebbe, Celeste, Martin-Liberal, Juan, Koch, Lukas, Richtig, Erika, Terheyden, Patrick, Weishaupt, Carsten, Mohr, Peter, Semiletova, Yulia, Casilda Llacer Perez, Brossart, Peter, Bauernfeind, Franz Georg, Fluck, Michael, Poltoratskiy, Artem, Sekacheva, Marina, Soria, Ainara, Schmitt-Bormann, Beate, Gonzalez, Marina, Heß, Jana, Wengenmayer, Peter, Seibel, Tobias, Koch, Sven D, Quintini, Gianluca, Codó, Paula, Falk, Martin, Schönborn-Kellenberger, Oliver, Gnad-Vogt, Ulrike
Published:	BMJ Publishing Group LTD
Subjects:	Head & neck cancer Biomarkers Squamous cell carcinoma Vaccines Cell death Metastasis Melanoma Peptides Tumors Cancer therapies Immunology Proteins Skin cancer
Online Access:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!